In conclusion, the findings of this study indicate that high intra-tumoral and pre-operative sera MMP-9 levels, along with intra-tumoral MMP-9 activity, are associated with poorer OS in glioblastoma and BM patients. This evidence concerns the gene MMP9 and glioblastoma.